Resolution of type II diabetes following RNY gastric bypass surgery: can gene expression profiling reveal the underlying dynamic mechanisms?
Resolution of type II diabetes following RNY gastric bypass surgery: can gene expression profiling reveal the underlying dynamic mechanisms?
批准号:
MR/K014536/1
负责人:
Alexandra Blakemore
金额:
$12.81万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
With recent increases in the number of people with obesity, the number of people with diabetes is also rapidly increasing, both in the UK and worldwide. Although we know that the obese are at greater risk of becoming diabetic, how and why this happens is poorly understood. We also do not understand why some extremely obese individuals do not become diabetic.It is now becoming common for severe obesity to be treated by some form of weight-loss surgery. Surprisingly, in addition to the expected weight loss, some types of surgery can sometimes also 'cure' diabetes - even before there has been any weight loss. This provides an opportunity to investigate the causes of diabetes (apart from obesity), and possibly to identify new ways of treating or curing it.We will take blood and tissue samples from patients who are having weight-loss surgery, both before surgery and at various times afterwards. From these samples, we will determine which genes are switched on or off following the surgery, and by comparing patients whose diabetes was or was not cured by the surgery with those who have never had diabetes, we will try to find genes that are important in diabetes. We will then try to understand how these diabetes-related genes are controlled, by finding genetic differences between patients that help to explain whether the genes were turned on or off by a lot or just a little. To check that our results are not due to chance, we will look for similar results in additional groups of weight-loss surgery patients.The results of this research may help to identify patients who will benefit most from weight-loss surgery. It may also provide new ideas about how to develop drugs that can treat or cure diabetes.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/srep04954
发表时间:
2014-05-14
期刊:
Scientific reports
影响因子:
4.6
作者:
[Buxton JL, Suderman M, Pappas JJ, Borghol N, McArdle W, Blakemore AI, Hertzman C, Power C, Szyf M, Pembrey M]
通讯作者:
Pembrey M
DOI:
10.1111/cob.12145
发表时间:
2016-06-01
期刊:
CLINICAL OBESITY
影响因子:
3.3
作者:
[O'Kane, Mary, Parretti, Helen M., Barth, Julian H.]
通讯作者:
Barth, Julian H.
DOI:
10.1371/journal.pone.0099133
发表时间:
2014
期刊:
PloS one
影响因子:
3.7
作者:
[Buxton JL, Das S, Rodriguez A, Kaakinen M, Couto Alves A, Sebert S, Millwood IY, Laitinen J, O'Reilly PF, Jarvelin MR, Blakemore AI]
通讯作者:
Blakemore AI
Genetic determinants of leucocyte telomere length in children: a neglected and challenging field.
儿童白细胞端粒长度的遗传决定因素:一个被忽视且具有挑战性的领域。
DOI:
10.1111/ppe.12173
发表时间:
2015
期刊:
Paediatric and perinatal epidemiology
影响因子:
2.8
作者:
[Stathopoulou MG]
通讯作者:
Stathopoulou MG
DOI:
10.1371/journal.pone.0080094
发表时间:
2013
期刊:
PloS one
影响因子:
3.7
作者:
[Ala-Mursula L, Buxton JL, Ek E, Koiranen M, Taanila A, Blakemore AI, Järvelin MR]
通讯作者:
Järvelin MR
共 8 条
国内基金
海外基金
登录
查看更多内容
铋基邻近双金属位点Type B异质结光热催化合成氨机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:30.0万元
-
批准年份:2024
-
负责人:黎景卫
-
依托单位:
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
-
批准号:82372202
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯旭敏
-
依托单位:
损伤线粒体传递机制介导成纤维细胞/II型肺泡上皮细胞对话在支气管肺发育不良肺泡发育阻滞中的作用
-
批准号:82371721
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王星云
-
依托单位:
GPSM1介导Ca2+循环-II型肌球蛋白网络调控脂肪产热及代谢稳态的机制研究
-
批准号:82370879
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:严婧
-
依托单位:
二型聚合函数基于扩展原理的构造与表示问题
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:张炜
-
依托单位:
真菌中I型-III型聚酮杂合类天然产物的基因组挖掘
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:孔德坤
-
依托单位:
智能型Type-I光敏分子构效设计及其抗耐药性感染研究
-
批准号:22207024
-
项目类别:青年科学基金项目(C类)
-
资助金额:20.0万元
-
批准年份:2022
-
负责人:赵琦
-
依托单位:
TypeⅠR-M系统在碳青霉烯耐药肺炎克雷伯菌流行中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:蒋晓飞
-
依托单位:
替加环素耐药基因 tet(A) type 1 变异体在碳青霉烯耐药肺炎克雷伯菌中的流行、进化和传播
-
批准号:LY22H200001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:蔡加昌
-
依托单位:
面向手性α-氨基酰胺药物的新型不对称Ugi-type 反应开发
-
批准号:LY22B020003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:李绍玉
-
依托单位: